---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-178328"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T14:58:14.392694+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inhibikase Therapeutics announces 1-for-6 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse stock split effective June 30, 2023; shares outstanding reduced from ~31.6M to ~5.3M.
- Stockholder approval obtained on June 23, 2023; no fractional shares issued, fractional holders get full share.
- CUSIP changed to 45719W205; trading symbol remains 'IKT'.
- Proportional adjustments made to stock options and warrants exercise prices and shares.
- Split intended to meet Nasdaq minimum bid price requirement.

## SEC filing metadata
- accession: 0001193125-23-178328
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312523178328/0001193125-23-178328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312523178328/d517782d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-178328
- JSON: https://secwatch.observer/filing/0001193125-23-178328.json
- Plain text: https://secwatch.observer/filing/0001193125-23-178328.txt

## Key facts
- Governance Changes
  Inhibikase Therapeutics, Inc.: 1-for-6 reverse stock split via charter amendment (effective 2023-06-30).
  - Change: charter amendment
  - Effective: 2023-06-30
  source text: On June 28, 2023, Inhibikase Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretary of State of the State of Delaware (the “Certificate of Amendment”) to effect a 1-for-6 reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), on June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750149/000119312523178328/0001193125-23-178328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.